Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1213PDF: 973HTML: 200 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1279HTML: 296PDF: 927Suppl. Files: 442 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1369PDF: 814HTML: 3113 -
PREVALENCE OF SICKLE CELL TRAIT IN THE SOUTHERN SUBURBS OF BEIRUT, LEBANON
4083PDF: 1003HTML: 19152 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4054PDF: 1230HTML: 1948Table 1: 191 -
-
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
1014PDF: 369HTML: 86 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3580PDF: 1105HTML: 23328 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1075PDF: 838HTML: 234 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1835PDF: 1043HTML: 231 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4265PDF: 1366HTML: 2033 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1349HTML: 385PDF: 812 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
967PDF: 1139Suppl. Files: 142HTML: 66 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2092PDF: 1257Html: 274 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1581PDF: 800HTML: 157 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
960PDF: 530HTML: 719 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2374PDF: 848HTML: 2450 -
COMPARISON OF IL-34, ELASTOGRAPHY, AND BIOPSY IN THE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS B Evaluating Non-Invasive and Invasive Methods in Liver Fibrosis
520PDF: 282Html: 23 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1175PDF: 1058HTML: 187 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2143PDF: 1567HTML: 258 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3350PDF: 1286HTML: 1856Fig.1: 196Fig. 2: 199 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1700PDF: 830HTML: 142 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2604PDF: 933HTML: 3597 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2780PDF: 1002HTML: 5511







